GlassScriptPhysician profile
Girish D Patel
NPI 1447314190
$1,548.92
in general payments reported to CMS, 2019-2025
20 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.19 · 2020: $272 · 2021: $378 · 2022: $260 · 2023: $236 · 2024: $182 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.43 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $553.43 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $191.16 | 2020-2022 | |
| Abbvie INC. | $148.88 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $129.20 | 2020-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $109.25 | 2021-2025 | Trelegy Ellipta |
| Pfizer INC. | $57.99 | 2020-2023 | |
| Amarin Pharma, INC. | $57.77 | 2020-2021 | |
| Boston Scientific Corporation | $36.29 | 2023 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.40 | 2020-2025 | Jardiance |
| Exact Sciences Corporation | $31.25 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $31.16 | 2023-2025 | |
| Amgen INC. | $28.34 | 2023 | Otezla, Repatha |
| Biohaven Pharmaceutical Holding Company LTD. | $23.19 | 2022 | |
| Abbott Laboratories | $18.76 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.74 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17.59 | 2019 | |
| Merck Sharp & Dohme LLC | $16.72 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.80 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.34 | 2024 | Voquezna |
| Almatica Pharma LLC | $14.66 | 2023 | Loreev Xr, Sertraline Hcl, Gralise |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Girish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.